Modulating immunosuppression in liver transplant patients with COVID-19
Gut
.
2021 Jul;70(7):1412-1414.
doi: 10.1136/gutjnl-2020-322620.
Epub 2020 Aug 18.
Authors
Manuel Rodriguez-Peralvarez
1
2
3
,
Magdalena Salcedo
3
4
,
Jordi Colmenero
3
5
,
Jose Antonio Pons
6
Affiliations
1
Hepatology and Liver Transplantation, Reina Sofia University Hospital, Cordoba, Andalucía, Spain ropeml@hotmail.com.
2
Grupo G02, Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain.
3
CIBEREHD, Madrid, Madrid, Spain.
4
Hepatology, Hospital General Universitario Gregorio Marañón, Madrid, Madrid, Spain.
5
Hepatology and Liver Transplantation, Hospital Clinic, Barcelona, Catalunya, Spain.
6
Virgen de la Arrixaca University Hospital, El Palmar, Murcia, Spain.
PMID:
32816964
DOI:
10.1136/gutjnl-2020-322620
No abstract available
Keywords:
immunoregulation; liver transplantation.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Graft Rejection
Humans
Immunosuppression Therapy / adverse effects
Liver Transplantation*
SARS-CoV-2